Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
NCT ID: NCT06930677
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
72 participants
INTERVENTIONAL
2025-04-17
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genicular Artery Embolisation for Knee Osteoarthritis II
NCT05423587
Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA)
NCT03362957
Effect of Genicular Arteries Embolization in Symptomatic Knee Osteoarthritis LipioJoint-2
NCT06497140
Geniculate Artery Embolization for Treatment of Osteoarthritis
NCT04379700
Geniculate Artery Embolization for the Treatment of Knee Pain
NCT02850068
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MSK embolization
embolization therapy
MSK embolization
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
embolization therapy
MSK embolization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Life expectancy less than 6 months
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Next Biomedical Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Ghent
Ghent, , Belgium
Uz Leuven
Leuven, , Belgium
Elisabeth-Tweesteden Hospital
Tilburg, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
University Hospital Ghent
Role: primary
UZ LEUVEN
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GENTILLE
Identifier Type: OTHER
Identifier Source: secondary_id
TAME 003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.